VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CTVACorteva, Inc.
$78.56$52.7B
Research
OverviewAnalysis
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

CTVA logoCorteva, Inc.(CTVA)Earnings, Financials & Key Ratios

CTVA•NYSE
49.1× P/E·Price updated Jun 19, 2026
SectorBasic MaterialsIndustryAgricultural InputsSub-IndustrySeeds and crop genetics
AboutCorteva, Inc. operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was incorporated in 2018 and is headquartered in Indianapolis, Indiana.Show more
  • Revenue$17.4B+2.9%
  • EBITDA$3.82B+15.0%
  • Net Income$1.09B+20.6%
  • EPS (Diluted)1.60+23.1%
  • Gross Margin43.59%-0.1%
  • EBITDA Margin21.96%+11.8%
  • Operating Margin15.05%+21.4%
  • Net Margin6.29%+17.2%
  • ROE4.52%+22.8%

CTVA Key Insights

Corteva, Inc. (CTVA) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓FCF machine: 16.2% free cash flow margin
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 3.3% through buybacks

✗Weaknesses

  • ✗Weak 3Y average ROE of 3.7%

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when CTVA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CTVA Price & Volume

Corteva, Inc. (CTVA) stock price & volume — 10-year historical chart

Loading chart...

CTVA Growth Metrics

Corteva, Inc. (CTVA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years4.12%
3 Years-0.1%
TTM6.27%

Profit CAGR

10 Years-
5 Years9.94%
3 Years-1.56%
TTM1.93%

EPS CAGR

10 Years-
5 Years11.95%
3 Years0.42%
TTM3.63%

Return on Capital

10 Years3.86%
5 Years6.33%
3 Years7.25%
Last Year8.56%

CTVA Recent Earnings

Corteva, Inc. (CTVA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 10/12 qtrs (83%)●Beat Revenue 5/12 qtrs (42%)
Q2 2026Latest
May 5, 2026
Metric
Actual
Est
EPS
$1.50+28.2%
$1.17
Rev
$4.9B+5.7%
$4.6B
Q1 2026
Feb 3, 2026
Metric
Actual
Est
EPS
$0.22-1.3%
$0.22
Rev
$3.9B-7.8%
$4.2B
Q4 2025
Nov 4, 2025
Metric
Actual
Est
EPS
$0.23+54.6%
$0.51
Rev
$2.6B+6.0%
$2.5B
Q3 2025
Aug 6, 2025
Metric
Actual
Est
EPS
$2.20+16.4%
$1.89
Rev
$6.5B+3.0%
$6.3B
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 5, 2026
$1.50vs $1.17+28.2%
$4.9Bvs $4.6B+5.7%
Q1 2026Feb 3, 2026
$0.22vs $0.22-1.3%
$3.9Bvs $4.2B-7.8%
Q4 2025Nov 4, 2025
$0.23vs $0.51+54.6%
$2.6Bvs $2.5B+6.0%
Q3 2025Aug 6, 2025
$2.20vs $1.89+16.4%
$6.5Bvs $6.3B+3.0%
Based on last 12 quarters of dataView full earnings history →

CTVA Peer Comparison

Corteva, Inc. (CTVA) competitors in Seeds and crop genetics — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
FMC logoFMCFMC CorporationDirect Competitor1.44B11.55-0.65-18.34%-72.93%-82.27%2.00
CF logoCFCF Industries Holdings, Inc.Direct Competitor15.81B102.9311.4719.34%23.73%22.29%0.51
MOS logoMOSThe Mosaic CompanyDirect Competitor7.28B22.9013.478.36%6.03%5.85%0.43
NTR logoNTRNutrien Ltd.Direct Competitor30.24B62.8613.265.33%8.6%9.47%0.51
AMGN logoAMGNAmgen Inc.Direct Competitor182.2B337.6023.729.92%20.95%89.41%6.31
AVD logoAVDAmerican Vanguard CorporationDirect Competitor75.81M2.65-1.51-5.88%-8.71%-21.86%0.99
DD logoDDDuPont de Nemours, Inc.Product Competitor19.55B47.69-25.64-44.7%-0.3%-0.15%0.23
DOW logoDOWDow Inc.Product Competitor22.83B31.73-8.60-6.97%-7.02%-15.35%1.12

Compare CTVA vs Peers

Corteva, Inc. (CTVA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs FMC

Most directly comparable listed peer for CTVA.

Scale Benchmark

vs AMGN

Larger-name benchmark to compare CTVA against a more recognizable public peer.

Peer Set

Compare Top 5

vs FMC, CF, MOS, NTR

CTVA Income Statement

Corteva, Inc. (CTVA) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue
14.24B14.29B13.85B14.22B15.65B17.45B17.23B16.91B17.4B17.89B
Revenue Growth %
-0.33%-3.09%2.68%10.11%11.5%-1.31%-1.85%2.92%6.27%
Cost of Goods Sold
8.4B9.95B8.57B8.51B9.22B10.44B9.92B9.53B9.82B6.99B
COGS % of Revenue
59%69.63%61.93%59.84%58.89%59.79%57.59%56.36%56.41%-
Gross Profit
5.84B▲ 0%
4.34B▼ 25.7%
5.27B▲ 21.5%
5.71B▲ 8.3%
6.43B▲ 12.7%
7.02B▲ 9.1%
7.31B▲ 4.1%
7.38B▲ 1.0%
7.58B▲ 2.8%
6B▲ 0%
Gross Margin %
41%30.37%38.07%40.16%41.11%40.21%42.41%43.64%43.59%33.51%
Gross Profit Growth %
--25.68%21.48%8.33%12.7%9.08%4.09%1%2.79%-
Operating Expenses
5.65B4.79B4.69B4.87B5.12B5.09B5.2B5.28B4.97B5.46B
OpEx % of Revenue
39.68%33.51%33.85%34.23%32.69%29.17%30.16%31.25%28.54%-
Selling, General & Admin
2.97B3.04B3.06B3.04B3.21B3.17B3.18B3.2B3.49B3.62B
SG&A % of Revenue
20.87%21.29%22.14%21.4%20.5%18.18%18.44%18.9%20.07%-
Research & Development
1.51B1.35B1.15B1.14B1.19B1.22B1.34B1.4B1.47B1.48B
R&D % of Revenue
10.6%9.48%8.28%8.03%7.58%6.97%7.76%8.29%8.47%-
Other Operating Expenses
1.17B391M475M682M722M702M683M685M02M
Operating Income
188M▲ 0%
-448M▼ 338.3%
584M▲ 230.4%
843M▲ 44.3%
1.32B▲ 56.2%
1.93B▲ 46.4%
2.11B▲ 9.4%
2.1B▼ 0.7%
2.62B▲ 25.0%
2.47B▲ 0%
Operating Margin %
1.32%-3.14%4.22%5.93%8.41%11.05%12.25%12.4%15.05%13.82%
Operating Income Growth %
--338.3%230.36%44.35%56.23%46.39%9.44%-0.66%24.95%-
EBITDA
458M2.34B2.18B2.02B2.56B3.15B3.32B3.32B3.82B3.38B
EBITDA Margin %
3.22%16.39%15.77%14.21%16.35%18.05%19.28%19.65%21.96%18.89%
EBITDA Growth %
-411.35%-6.79%-7.47%26.73%23.09%5.4%0.06%15.02%-3.81%
D&A (Non-Cash Add-back)
270M2.79B1.6B1.18B1.24B1.22B1.21B1.23B1.2B907M
EBIT
-300M-6.47B-180M720M2.38B1.5B1.33B1.51B1.87B1.05B
Net Interest Income
-74M-251M-77M11M47M45M50M-101M-44M-40M
Interest Income
086M59M56M77M124M283M132M136M104M
Interest Expense
74M337M136M45M30M79M233M233M180M180M
Other Income/Expense
-562M-6.36B-900M-168M1.03B-502M-1.02B-821M-931M-711M
Pretax Income
-374M▲ 0%
-6.81B▼ 1719.8%
-316M▲ 95.4%
675M▲ 313.6%
2.35B▲ 247.6%
1.43B▼ 39.2%
1.09B▼ 23.4%
1.27B▲ 16.7%
1.69B▲ 32.4%
1.76B▲ 0%
Pretax Margin %
-2.63%-47.64%-2.28%4.75%14.99%8.17%6.35%7.54%9.7%9.85%
Income Tax
-2.52B-31M-46M-81M524M210M152M412M484M500M
Effective Tax Rate %
674.87%0.46%14.56%-12%22.34%14.73%13.91%32.31%28.67%28.38%
Net Income
2.53B▲ 0%
-5.07B▼ 299.9%
-959M▲ 81.1%
681M▲ 171.0%
1.76B▲ 158.3%
1.15B▼ 34.8%
735M▼ 35.9%
907M▲ 23.4%
1.09B▲ 20.6%
1.16B▲ 0%
Net Margin %
17.79%-35.45%-6.93%4.79%11.24%6.57%4.27%5.36%6.29%6.5%
Net Income Growth %
--299.88%81.07%171.01%158.3%-34.79%-35.92%23.4%20.62%1.93%
Net Income (Continuing)
2.57B-6.78B-270M756M1.82B1.22B941M863M1.2B1.26B
Discontinued Operations
01.75B-671M-55M-53M-58M-194M56M-99M-3M
Minority Interest
172M493M246M239M239M239M242M241M242M243M
EPS (Diluted)
3.38▲ 0%
-6.76▼ 300.0%
-1.28▲ 81.1%
0.91▲ 171.1%
2.37▲ 160.4%
1.58▼ 33.3%
1.03▼ 34.8%
1.30▲ 26.2%
1.60▲ 23.1%
1.73▲ 0%
EPS Growth %
--300%81.07%171.09%160.44%-33.33%-34.81%26.21%23.08%3.63%
EPS (Basic)
3.38-6.76-1.280.912.391.591.041.311.61-
Diluted Shares Outstanding
749.4M749.4M749.5M751.2M741.6M724.5M711.9M696M673.17M673.6M
Basic Shares Outstanding
749.4M749.4M749.5M748.7M735.9M720.8M709M693.7M673.17M672.5M
Dividend Payout Ratio
72.1%--56.97%22.57%36.44%59.73%50.5%43.42%-

CTVA Balance Sheet

Corteva, Inc. (CTVA) balance sheet — assets, liabilities & shareholders' equity

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets
23.05B22.97B13.52B14.77B15.55B16.8B16.26B15.1B17.34B17.39B
Cash & Short-Term Investments
8.76B2.27B1.77B3.79B4.54B3.31B2.74B3.17B4.53B1.97B
Cash Only
7.81B2.27B1.76B3.53B4.46B3.19B2.64B3.11B4.52B1.96B
Short-Term Investments
952M5M5M269M86M124M98M63M9M2M
Accounts Receivable
5.24B5.26B5.53B4.93B4.81B5.7B5.49B5.68B6.37B9.09B
Days Sales Outstanding
134.29134.38145.73126.47112.17119.21116.28122.53133.64162.81
Inventory
8.63B5.31B5.03B4.88B5.18B6.81B6.9B5.43B5.67B5.2B
Days Inventory Outstanding
375.04194.83214.19209.47205.07238.22253.84208.07210.72267.59
Other Current Assets
423M10.13B1.19B1.17B1.01B968M1.13B820M767M1.13B
Total Non-Current Assets
89.91B85.71B28.88B27.88B26.8B25.82B26.74B25.73B25.51B25.33B
Property, Plant & Equipment
12.44B4.54B4.55B4.4B4.33B4.25B4.29B4.1B4.22B9.62B
Fixed Asset Turnover
1.15x3.14x3.05x3.23x3.62x4.10x4.02x4.12x4.12x3.22x
Goodwill
45.59B10.19B10.23B10.27B10.11B9.96B10.61B10.41B10.46B10.41B
Intangible Assets
012.05B11.42B10.75B10.04B9.34B9.63B8.88B8.3B8.15B
Long-Term Investments
1.59B138M66M66M76M102M115M134M160M435M
Other Non-Current Assets
29.81B58.48B2.33B1.94B1.8B1.69B1.52B1.81B2.04B-3.24B
Total Assets
112.96B▲ 0%
108.68B▼ 3.8%
42.4B▼ 61.0%
42.65B▲ 0.6%
42.34B▼ 0.7%
42.62B▲ 0.6%
43B▲ 0.9%
40.83B▼ 5.0%
42.84B▲ 4.9%
42.72B▲ 0%
Asset Turnover
0.13x0.13x0.33x0.33x0.37x0.41x0.40x0.41x0.41x0.42x
Asset Growth %
--3.79%-60.99%0.59%-0.72%0.65%0.89%-5.05%4.95%7.76%
Total Current Liabilities
12.14B13.31B8.24B8.55B9.56B10.74B10.41B10.39B12.13B11.85B
Accounts Payable
4.83B3.8B3.7B3.62B4.13B4.89B4.28B4.04B4.4B4.19B
Days Payables Outstanding
209.87139.35157.58155.1163.34171.2157.48154.71163.54218.69
Short-Term Debt
2.78B2.13B3M3M17M23M197M750M894M1.67B
Deferred Revenue (Current)
2.01B2.21B2.58B2.66B3.2B3.39B3.41B3.29B3.58B7.19B
Other Current Liabilities
2.52B3.17B381M232M000003.22B
Current Ratio
1.90x1.73x1.64x1.73x1.63x1.56x1.56x1.45x1.43x1.47x
Quick Ratio
1.19x1.33x1.03x1.16x1.08x0.93x0.90x0.93x0.96x1.03x
Cash Conversion Cycle
299.45189.86202.34180.83153.9186.23212.65175.89180.82211.7
Total Non-Current Liabilities
25.89B20.22B9.6B9.04B7.16B6.33B7.31B6.41B6.33B6.26B
Long-Term Debt
10.29B5.72B115M1.1B1.1B1.28B2.29B1.95B1.69B1.68B
Capital Lease Obligations
4M67M5M395M3M2M0000
Deferred Tax Liabilities
5.84B0920M893M1.22B1.12B899M478M251M1.17B
Other Non-Current Liabilities
9.71B12.81B8.56B6.14B4.84B3.93B4.12B3.98B4.4B4.29B
Total Liabilities
38.03B33.53B17.84B17.59B16.72B17.08B17.72B16.8B18.46B18.11B
Total Debt
13.07B7.94B127M1.11B1.12B1.31B2.49B2.7B2.58B3.36B
Net Debt
5.26B5.67B-1.64B-2.42B-3.34B-1.88B-155M-403M-1.94B1.39B
Debt / Equity
0.17x0.11x0.01x0.04x0.04x0.05x0.10x0.11x0.11x0.14x
Debt / EBITDA
28.54x3.39x0.06x0.55x0.44x0.41x0.75x0.81x0.68x0.99x
Net Debt / EBITDA
11.49x2.42x-0.75x-1.20x-1.30x-0.60x-0.05x-0.12x-0.51x0.41x
Interest Coverage
-4.05x-19.20x-1.32x16.00x79.20x19.05x5.69x6.47x10.38x5.82x
Total Equity
74.93B▲ 0%
75.15B▲ 0.3%
24.55B▼ 67.3%
25.06B▲ 2.1%
25.62B▲ 2.2%
25.54B▼ 0.3%
25.28B▼ 1.0%
24.03B▼ 4.9%
24.39B▲ 1.5%
24.61B▲ 0%
Equity Growth %
-0.29%-67.33%2.07%2.23%-0.32%-1.03%-4.94%1.48%6.6%
Book Value per Share
99.99100.2832.7633.3634.5535.2535.5134.5336.2336.53
Total Shareholders' Equity
74.76B74.66B24.31B24.82B25.38B25.3B25.04B23.79B24.14B24.36B
Common Stock
007M7M7M7M7M7M7M7M
Retained Earnings
175M0-425M0524M250M-41M55M-67M436M
Treasury Stock
0000000000
Accumulated OCI
-381M74.66B-3.27B-2.89B-2.9B-2.81B-2.68B-3.47B-2.8B-2.94B
Minority Interest
172M493M246M239M239M239M242M241M242M243M

CTVA Cash Flow Statement

Corteva, Inc. (CTVA) cash flow — operating, investing & free cash flow history

MetricDec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations
247M483M1.07B2.06B2.73B872M1.77B2.15B3.41B2.63B
Operating CF Margin %
1.73%3.38%7.73%14.52%17.42%5%10.27%12.69%19.57%-
Operating CF Growth %
-95.55%121.53%92.9%32.12%-68.02%102.87%21.25%58.79%126.49%
Net Income
2.71B-5.07B-941M701M1.82B1.21B941M863M1.1B1.16B
Depreciation & Amortization
1.54B2.79B1.6B1.18B1.24B1.22B1.21B1.23B1.2B1.2B
Stock-Based Compensation
0084M0055M0000
Deferred Taxes
-3.02B31M-477M-330M174M-286M-438M-365M-41M-2M
Other Non-Cash Items
-334M5.67B1.36B19M-1.17B224M841M512M599M-3.26B
Working Capital Changes
-656M-2.94B-556M497M656M-1.55B-786M-92M540M3.53B
Change in Receivables
-162M-1.52B0187M-113M-997M358M-705M-261M2.24B
Change in Inventory
-1.01B-498M74M104M-422M-1.72B57M1.11B-35M25M
Change in Payables
934M642M149M-118M524M807M-663M-115M231M200M
Cash from Investing
386M-505M-904M-674M-362M-632M-1.99B-589M-543M-586M
Capital Expenditures
-1.11B-1.5B-1.16B-475M-573M-605M-595M-597M-591M-578M
CapEx % of Revenue
7.82%10.51%8.4%3.34%3.66%3.47%3.45%3.53%3.4%3.23%
Acquisitions
1.32B01M-10M-4M-12M-1.46B-7M00
Investments
----------
Other Investing
-214M75M236M85M74M34M45M-34M37M48M
Cash from Financing
2.4B-2.62B-2.93B303M-1.27B-1.18B-99M-1.2B-1.64B-2.25B
Debt Issued (Net)
4.03B-4.8B-7.67B998M11M205M1.11B240M-141M-1.51B
Equity Issued (Net)
265M0-25M-275M-950M-1B-756M-1.01B-983M-783M
Dividends Paid
-988M-2.81B-511M-388M-397M-418M-439M-458M-475M-480M
Share Repurchases
00-25M-275M-950M-1B-756M-1.01B-1.07B-1.05B
Other Financing
-903M4.98B5.28B-32M70M33M-18M28M-45M522M
Net Change in Cash
3.2B▲ 0%
-2.89B▼ 190.2%
-2.85B▲ 1.3%
1.7B▲ 159.6%
963M▼ 43.4%
-1.22B▼ 226.5%
-460M▲ 62.2%
264M▲ 157.4%
1.1B▲ 316.3%
-358M▲ 0%
Free Cash Flow
-866M▲ 0%
-1.02B▼ 17.6%
-93M▲ 90.9%
1.59B▲ 1808.6%
2.15B▲ 35.6%
267M▼ 87.6%
1.17B▲ 339.7%
1.55B▲ 31.9%
2.81B▲ 81.8%
2.05B▲ 0%
FCF Margin %
-6.08%-7.13%-0.67%11.18%13.76%1.53%6.82%9.16%16.18%11.47%
FCF Growth %
--17.55%90.86%1808.6%35.56%-87.6%339.7%31.86%81.85%-2.38%
FCF per Share
-1.16-1.36-0.122.122.900.371.652.224.183.05
FCF Conversion (FCF/Net Income)
0.10x-0.10x-1.12x3.03x1.55x0.76x2.41x2.36x3.11x1.77x
Interest Paid
0923M263M36M30M75M234M244M191M0
Taxes Paid
0961M234M229M341M467M535M707M750M0

CTVA Key Ratios

Corteva, Inc. (CTVA) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20182019202020212022202320242025TTM
Return on Equity (ROE)
-6.75%-1.92%2.74%6.94%4.48%2.89%3.68%4.52%4.62%
Return on Invested Capital (ROIC)
-0.42%0.84%2.78%4.4%6.3%6.49%6.45%8.53%7.17%
Gross Margin
30.37%38.07%40.16%41.11%40.21%42.41%43.64%43.59%33.51%
Net Margin
-35.45%-6.93%4.79%11.24%6.57%4.27%5.36%6.29%6.5%
Debt / Equity
0.11x0.01x0.04x0.04x0.05x0.10x0.11x0.11x0.14x
Interest Coverage
-19.20x-1.32x16.00x79.20x19.05x5.69x6.47x10.38x5.82x
FCF Conversion
-0.10x-1.12x3.03x1.55x0.76x2.41x2.36x3.11x1.77x
Revenue Growth
0.33%-3.09%2.68%10.11%11.5%-1.31%-1.85%2.92%6.27%
Related:CTVA Dividend History·CTVA Revenue History·CTVA Price History·CTVA P/E History·CTVA Financial Ratios·CTVA Institutional Holders

CTVA SEC Filings & Documents

Corteva, Inc. (CTVA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 5, 2026·SEC

Material company update

May 1, 2026·SEC

Material company update

Apr 14, 2026·SEC

10-K Annual Reports

3
FY 2026

Feb 12, 2026·SEC

FY 2025

Feb 14, 2025·SEC

FY 2024

Feb 8, 2024·SEC

10-Q Quarterly Reports

6
FY 2026

May 6, 2026·SEC

FY 2025

Nov 5, 2025·SEC

FY 2025

Aug 7, 2025·SEC

CTVA Frequently Asked Questions

Corteva, Inc. (CTVA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Corteva, Inc. (CTVA) reported $17.89B in revenue for fiscal year 2025. This represents a 26% increase from $14.24B in 2017.

Corteva, Inc. (CTVA) grew revenue by 2.9% over the past year. Growth has been modest.

Yes, Corteva, Inc. (CTVA) is profitable, generating $1.16B in net income for fiscal year 2025 (6.3% net margin).

Dividend & Returns

Yes, Corteva, Inc. (CTVA) pays a dividend with a yield of 0.90%. This makes it attractive for income-focused investors.

Corteva, Inc. (CTVA) has a return on equity (ROE) of 4.5%. This is below average, suggesting room for improvement.

Corteva, Inc. (CTVA) generated $2.05B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in CTVA back in 2017?

Total return calculator · dividends reinvested · 9+ years of data

See returns →

How much would $100/month in CTVA be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →